Premalignant hematological system disease
MONDO:0060782A hematologic disorder which does not display the morphologic and/or clinical characteristics of an overt malignancy. Representative examples include atypical lymphoproliferative disorders and myelodysplastic syndromes.
Also known as: premalignant hematologic condition
35 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New hope for heart patients: drugs target hidden inflammation from blood mutations
Disease control CompletedThis study tested two experimental drugs, DFV890 (a daily pill) and MAS825 (a single shot), in 31 adults with coronary heart disease and a blood condition called CHIP. The goal was to see if these drugs could reduce specific markers of inflammation linked to heart risk. The trial…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Hidden gene changes may raise heart risk even after quitting smoking
Knowledge-focused CompletedThis completed study looked at 1029 patients who had a heart attack or unstable angina and quit smoking. Researchers checked for certain gene mutations (called CHIP) in their blood. They wanted to see if these mutations are linked to a higher chance of future heart problems, like…
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:27 UTC